FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

CONCLUSION: FOXO1 may play a candidate oncogenic role in EOC, and FOXO1 is a useful independent prognostic marker in EOC, and it may provide a candidate target therapy in future. PMID: 32224523 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32224523?dopt=Abstract

Source: Cancer Biomarkers : Section A of Disease Markers - March 26, 2020 Category: Cancer & Oncology Authors: Liu L, Yi J, Yuan J, Yao T, Lin Z, Ning Y, Zeng Z Tags: Cancer Biomark Source Type: research